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Abstract 
In the present study, chitosan membranes capable of imitating permeation 
characteristics of diclofenac diethylamine across animal skin were prepared 
using cast drying method. The effect of concentration of chitosan, concentration 
of cross-linking agent (NaTPP), crosslinking time was studied using Taguchi 
design. Taguchi design ranked concentration of chitosan as the most important 
factor influencing the permeation parameters of diclofenac diethylamine. The 
flux of the diclofenac diethylamine solution through optimized chitosan 
membrane (T9) was found to be comparable to that obtained across rat skin. 
The mathematical model developed using multilinear regression analysis can 
be used to formulate chitosan membranes that can mimic the desired 
permeation characteristics. The developed chitosan membranes can be utilized 
as a substitute to animal skin for in vitro permeation studies. 
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Introduction 
Transdermal drug delivery systems (TDDS) deliver therapeutic quantities of drug through 
the skin into the systemic circulation for their general effects. Several transdermal drug 
delivery systems have been developed and introduced into the market place since 
introduction of scopolamine in 1981 [1]. Evaluation of TDDS can be performed either using 
in vivo methods or by in vitro studies. Animal models (hairless rat, rabbit, guinea pig etc.) 
and human volunteers are generally used for in vivo studies [2]. It is almost often 978  V. Sharma, R. K. Marwaha and H. Dureja:   
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undesirable and non convenient to use human volunteers for routine quality control 
permeability tests due to ethical reasons. Animal models are however very useful in 
toxicology and mechanistic studies but extrapolation of the results to human in vivo 
situation should be done with utmost caution [3]. In vitro studies can be performed with 
human skin, animal skin and artificial membranes. Human skin in vitro models are most 
reliable but may be difficult to conduct due to scarcity of human skin and the effect of 
anatomical site, gender, age and race on the skin permeability [4]. The permeability 
characteristics between human skin and animal skin may differ due to the difference in 
skin permeation pathways, lipid content and variation in water uptake [5]. The difficulty in 
obtaining human/animal skin and variation in their permeability has led research workers 
to opt for artificial membranes. Moreover, the ethical concern against the use of 
animal/human skin makes polymeric membranes as an alternative model for evaluation of 
transdermal permeation. Polymeric membranes of chitosan have been developed by 
various researchers to imitate the permeability characteristics with the animal skin [6–8]. 
Artificial membranes have certain advantages like controlled composition, ease of 
preparation, availability of raw material, reproducible results over biological membranes.  
Chitosan is a natural linear polysaccharide which is prepared from chitin by action of the 
enzyme chitin deacetylase. Chitosan is being widely used because of its biodegradability, 
biocompatibility and good film forming properties. Chitosan can be complexed with 
crosslinking agents like sodium citrate, sodium tripolyphosphate etc., which make chitosan 
a useful polymer for artificial membranes, microspheres, beads, wound dressings and 
nanoparticles. Diclofenac diethylamine, a topical non-steroidal anti-inflammatory drug, was 
used as a model drug for permeability evaluation through chitosan membranes. 
In the present study, chitosan membranes capable of simulating permeation character-
istics of diclofenac diethylamine across rat skin were prepared using Taguchi design. The 
objective behind the study was to identify the critical variables influencing the permeation 
characteristics through chitosan membranes. 
Materials and Methods  
Chitosan, 95% deacetylated (Sigma Aldrich, Switzerland), Diclofenac diethylamine (Arion 
Pharmaceuticals, Chandigarh), Sodium tripolyphosphate (Thomas and Baker, Mumbai), 
Glacial Acetic Acid (Ranbaxy Fine Chemicals Limited, New Delhi), HPLC grade Methanol 
(Ranbaxy Fine Chemicals Limited, New Delhi) were used as received. All other reagents 
were of analytical grade. 
Taguchi Design 
To study the effect of the process and formulation variables on permeation parameters of 
diclofenac diethylamine, the Taguchi design was applied. The Taguchi design utilizes 
orthogonal arrays from design of experiments theory to study a large number of variables 
with a small number of experiments. The use of orthogonal arrays significantly reduces the 
number of experimental configurations to be studied. Furthermore, the conclusions drawn 
from small scale experiments are valid over the entire experimental region spanned by the 
control factors and their settings [9–10]. To study three variables at three levels, Taguchi 
design revealed "L9" design, means that nine experiments are to be carried out. The study 
of three critical variables i.e. concentration of chitosan (X1), concentration of crosslinking   Permeability Evaluation Through Chitosan Membranes  979 
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agent, NaTPP (X2) and crosslinking time (X3) at 3 levels (low, medium and high) lead to 
formulation of nine chitosan membranes.  
Preparation of chitosan membranes 
All the chitosan membranes were prepared using cast drying method as reported by 
Dureja et al., [6]. Chitosan (powder) was dissolved in glacial acetic acid solution (2% v/v) 
to prepare chitosan solution (3–5 % w/v) and homogenized (2000 rpm). Then the solution 
was filtered through muslin cloth to remove debris and a portion was degassed by 
sonication at 25 °C for 20 min. The chitosan solution was cast on a polycarbonate petri 
dish and dried at 45 °C for 48 h. The dried membranes were crosslinked by dipping in a 
sodium tripolyphosphate solution (10 ml of 5–10% w/v) for 15–45 min. The membranes 
were further washed with distilled water to remove excess NaTPP. Freshly crosslinked 
membranes that were insoluble in phosphate buffer pH 7.4 (receptor solution) for more 
than 48 hrs were used for in vitro permeation studies. The formulation of chitosan 
membranes using Taguchi design (T1–T9) are shown in Table 1. 
Preparation and conditioning of rat skin 
Rat skin was obtained after sacrificing the animal by inhalation of excess chloroform. The 
protocol was approved by Institutional Ethical Committee. Dorsal skin portion of albino 
Wistar rats was shaved with an electrical hair clipper and excised after sacrificing. To 
remove small hairs, depilatory cream was applied over the skin of rat for half an hour and 
then washed with distilled water. Freshly prepared rat skin was washed with phosphate 
buffer solution pH 7.4 and conditioned under stirring in a receptor solution for 4 h before 
initiating in vitro permeation experiments. 
In vitro Permeation Study 
Franz diffusion cell apparatus (Hanson’s Research, USA) was used for in vitro permeation 
studies. Chitosan membranes or rat skin were clamped between donor and receptor 
compartments. Donor compartment was loaded with saturated solution of diclofenac 
diethylamine. The receptor compartment contained phosphate buffer pH 7.4 with formalin 
solution [0.1%w/v of 37–41% v/v] to prevent microbial growth. Stirring of receptor fluid was 
performed at 600 rpm and at 37±05 °C. Aliquots (0.5 ml) were withdrawn at various 
intervals and immediately analyzed for diclofenac  diethylamine by HPLC (Agilent 
Technologies 1200 series, Germany) using eclipse XDB-C18 column (4.6x150 mm), and 
UV detector (Dual wavelength) at 221nm by modifying the method as reported by Mulgund 
et al., [11]. A mixture of methanol and water (70:30) at flow rate of 1.0 ml min
−1 was used 
as mobile phase for diclofenac diethylamine.  
Results and Discussion 
Taguchi design was used to study the effect of concentration of chitosan, concentration of 
NaTPP and CL time on permeation parameters of diclofenac diethylamine (DDEA). Nine 
chitosan membranes (batch T1–T9) were developed (Table 1) and cumulative permeation 
of DDEA solution through these chitosan membranes was calculated. The permeation 
parameters i.e. flux and lag time  was calculated from the linear portion of the graph 
(cumulative amount of drug permeated versus time). The signal to noise ratio (SN number) 
was calculated for each experiment to determine the effect of each variable on the flux. 980  V. Sharma, R. K. Marwaha and H. Dureja:   
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The calculated flux, lag time, thickness and SN value of chitosan membranes (batches 
T1–T9) are presented in Table  1. Ranking of factors (Table 2) was determined using 
average SN value of each factor. 
Tab. 1.  Formulation of chitosan membrane (T1–T9) and permeation parameters 
Batch  
No. 
X1 
(%w/v) 
X2 
(%w/v) 
X3 (min) Flux±SD 
(µg.cm
−2.sec
−1)
Lag Time × 
60±SD (sec)
Thickness 
± SD 
(cm) 
SN Value
T1 1(3) 1(5) 1(15) 283.0±1.02 6.15±0.05  0.10±0.001  35.209 
T2 1(3)  2(7.5)  2(30) 115.8±0.70 19.74±0.03  0.10±0.004  24.980 
T3 1(3) 3(10)  3(45) 162.5±0.82 6.74±0.02  0.10±0.005  29.406 
T4 2(4) 1(5) 2(30) 182.7±1.05 7.62±0.05  0.08±0.002  34.566 
T5 2(4)  2(7.5)  3(45) 111.0±0.85 42.42±0.08  0.09±0.006  29.663 
T6 2(4) 3(10)  1(15) 69.6±0.94 4.69±0.06  1.05±0.008  24.658 
T7 3(5) 1(5) 3(45) 65.1±0.82 44.49±0.03  0.10±0.001  25.764 
T8 3(5)  2(7.5)  1(15) 52.8±1.13 16.82±0.04  0.09±0.004  21.322 
T9 3(5) 3(10) 2(30)  45.6±1.02 47.58±0.06  0.07±0.007  20.239 
Rat 
skin  – – –  36.6±0.91  52.68±0.09  0.08±0.07  – 
X1= concentration of chitosan, X2= concentration of NaTPP, X3= crosslinking time.  
Values in the bracket indicate real values. 
 
Tab. 2.   Ranking of factors 
Level X1  X2  X3 
1 29.865  31.846  27.663 
2 29.629  25.321  26.595 
3 22.441  24.767  28.277 
Δ 7.424  7.097  1.682 
Rank 1  2  3 
 
Taguchi design ranked the concentration of chitosan as the most important factor 
influencing the permeation parameters of DDEA through chitosan membranes followed by 
concentration of NaTPP (crosslinking agent). The flux value increases at low levels of 
chitosan concentration, concentration of NaTPP and CL time. However, the flux was found 
to decrease with high values of chitosan concentration, i.e. the value of flux decreases as 
the concentration of chitosan increases. At high values of CL time, as the concentration of 
chitosan increases, the value of flux decreases. At low values of CL time, the lag time 
values were found to be low. The lag time was found to be lowest in case of low value of 
CL time with mid value of concentration of chitosan, whereas lag time was highest in case 
of mid values of CL time and with high value of concentration of chitosan. The high level of 
concentration of chitosan causes high values of lag time except at low values of CL time. 
Similarly, high value of CL time with high concentration of chitosan causes higher lag time 
except at low concentration of chitosan.    Permeability Evaluation Through Chitosan Membranes  981 
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To determine the magnitude of contribution of different factors towards flux and lag time, 
multiple linear regression analysis was also performed. The real values of the factors were 
transformed to facilitate orthogonality of results and easy calculations. The effect plot of 
coefficients of flux is shown in Figure 1. 
The mathematical model developed from multiple linear regression analysis to estimate 
flux can be represented as: 
 Y=  120.9  − 66.3 X1 − 42.183 X2 − 11.133 X3  
where Y= flux (µg.cm
−2.sec
−1), X1= Concentration of chitosan (%w/v), X2 = Concentration 
of NaTPP (%w/v), X3 = CL time (sec). 
ANOVA was applied on the flux (Table 3) to study the fitting and significance of the model. 
F-test was carried out to compare the regression mean square with residual mean square, 
the ratio F= 6.170 show the regression to be significant. The estimated model, therefore, 
may be used to estimate the flux. The developed model can be further utilized to develop 
chitosan membranes of desired flux.  
 
Fig. 1.   Effect plot of coefficients of flux 
Tab. 3.   ANOVA of the regression (flux) 
  Degree of  
freedom 
Sum of  
Squares 
Mean  
Square 
F F-significance 
Regression 3  37794.45 12598.15 6.170233 0.03911 
Residual  5  10208.81 2041.762    
Total  8  48003.26     
 
The in vitro evaluation of newly developed transdermal drug delivery system is primarily 
performed by the researchers using rodents/rats due to their availability and ease of 
estimation. Therefore, the permeation parameters of diclofenac diethylamine from chitosan 982  V. Sharma, R. K. Marwaha and H. Dureja:   
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membranes were compared with dorsal skin of Wistar rats. It was observed that only batch 
T9 has comparable permeation characteristic of diclofenac  diethylamine solution as 
through rat skin with a correlation coefficient of R= 0.86. The low value of correlation 
coefficient may be attributed to less number of measured data points. The mathematical 
model developed using multilinear regression can be further utilized to develop a chitosan 
membrane which will exactly mimic the permeation characteristics with rat skin. 
Conclusion 
Transdermal drug delivery system has become established as an effective alternative 
during the past decades. The ethical concern against the use of animals or human 
volunteers makes polymeric membranes as an alternative model for evaluation of 
transdermal permeation. Chitosan membranes were developed using Taguchi design to 
mimic the permeability of diclofenac diethylamine through rat skin. Taguchi design ranked 
the concentration of chitosan as the most important factor affecting the permeation of 
DDEA through crosslinked chitosan membranes. The optimized chitosan membrane 
(batch T9) was found to have comparable permeation characteristics. The mathematical 
model developed can be used to formulate chitosan membranes with simulated 
permeation characteristics. The critical variables can be further optimized experimentally 
to simulate the permeation characteristics of DDEA through other animal skins or human 
skin. These membranes also offer significant advantages in terms of their ready 
availability, uniformity, tensile strength and chemical purity therefore; these membranes 
should be utilized for in vitro permeation study of TDDS. 
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